Evofem adds second manufacturer for Phexx, targets 40% cost cut

Go back to Evofem adds second manufacturer for Phexx, targets 40% cost cut

Evofem Biosciences Adds Additional Manufacturing Capacity for PHEXX® to Support Global Growth Strategy

September 23, 2026 4:05 PM EDT

-- Additional manufacturing source expected to improve supply chain flexibility and reduce unit costs by 40% or more following regulatory approval --

SAN DIEGO--(BUSINESS WIRE)-- Womens health innovator Evofem Biosciences, Inc. (OTCID: EVFM) has achieved an important milestone in its strategy to support long-term growth, enhance manufacturing flexibility, and reduce costs. Evofem has contracted with a second pharmaceutical manufacturer to produce PHEXX®... More